These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 36075195)
1. Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes. Grupper A; Rabinowich A; Ben Shabat I; Tzadok R; Schwartz D; Schwartz IF; Goykhman Y; Kliuk Ben-Bassat O; Baruch R; Shashar M; Cohen-Hagai K; Katchman H Am J Nephrol; 2022; 53(8-9):636-645. PubMed ID: 36075195 [TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease: A Unique Entity or Part of the Metabolic Syndrome or Both. Yip TC; Wong GL; Wong VW; Goh GB; Chan WK Med Clin North Am; 2023 May; 107(3):449-463. PubMed ID: 37001947 [TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. Chiriac S; Stanciu C; Girleanu I; Cojocariu C; Sfarti C; Singeap AM; Cuciureanu T; Huiban L; Muzica CM; Zenovia S; Nastasa R; Trifan A Can J Gastroenterol Hepatol; 2021; 2021():6696857. PubMed ID: 33505944 [TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170 [TBL] [Abstract][Full Text] [Related]
5. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis. Han AL BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056 [TBL] [Abstract][Full Text] [Related]
6. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697 [TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Bajaj S; Prajapati SK J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845 [TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560 [TBL] [Abstract][Full Text] [Related]
16. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease. Chinnadurai R; Chrysochou C; Kalra PA Nephron; 2019; 141(1):24-30. PubMed ID: 30384370 [TBL] [Abstract][Full Text] [Related]
17. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). Johnston MP; Patel J; Byrne CD Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic syndrome after kidney transplantation]. Nedbálková M; Svojanovský J; Trnavský K; Kuman M; Jarkovský J; Karpíšek M; Souček M Vnitr Lek; 2014 Mar; 60(3):196-204. PubMed ID: 24981694 [TBL] [Abstract][Full Text] [Related]
19. [Nonalcoholic fatty liver disease : Hepatic manifestations of metabolic syndrome]. Roeb E Inn Med (Heidelb); 2023 Apr; 64(4):323-328. PubMed ID: 36580094 [TBL] [Abstract][Full Text] [Related]
20. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. El Hadi H; Di Vincenzo A; Vettor R; Rossato M Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]